Neurogastrx
PrivateLast Round
Series B
Aug 26, 2021
Total Funding Raised
$105M
Company Overview
Neurogastrx is a biotechnology company that develops specialized therapies aimed at treating gastrointestinal disorders related to the enteric nervous system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurogastrx Comparables
Compare Neurogastrx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CinDome Pharma | 91% | |
| Retromer Therapeutics | 87% | |
| Renexxion, Inc. | 81% | |
Neurogastrx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 26, 2021 | ||||
| Series A | Jan 4, 2018 |
Key People
Founding team and executive leadership
Neurogastrx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| M Ventures | Series B, Series A |
| OrbiMed | Series B, Series A |
| 5AM Ventures | Series B, Series A |
| venBio | Series B, Series A |
| RTW Investments | Series B |
| Marshall Wace | Series B |
| Samsara BioCapital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2021
$60M round led by Vivo Capital.
- Jan 4, 2018
$45M round led by OrbiMed, 5AM Ventures, and venBio.
Neurogastrx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurogastrx's valuation, stock price, and market status.